292 related articles for article (PubMed ID: 12218628)
1. cDNA microarray analysis of vestibular schwannomas.
Welling DB; Lasak JM; Akhmametyeva E; Ghaheri B; Chang LS
Otol Neurotol; 2002 Sep; 23(5):736-48. PubMed ID: 12218628
[TBL] [Abstract][Full Text] [Related]
2. Retinoblastoma-cyclin-dependent kinase pathway deregulation in vestibular schwannomas.
Lasak JM; Welling DB; Akhmametyeva EM; Salloum M; Chang LS
Laryngoscope; 2002 Sep; 112(9):1555-61. PubMed ID: 12352662
[TBL] [Abstract][Full Text] [Related]
3. Global gene expression profiling and tissue microarray reveal novel candidate genes and down-regulation of the tumor suppressor gene CAV1 in sporadic vestibular schwannomas.
Aarhus M; Bruland O; Sætran HA; Mork SJ; Lund-Johansen M; Knappskog PM
Neurosurgery; 2010 Oct; 67(4):998-1019; discussion 1019. PubMed ID: 20881564
[TBL] [Abstract][Full Text] [Related]
4. Mutations of the neurofibromatosis type 2 gene and lack of the gene product in vestibular schwannomas.
Sainz J; Huynh DP; Figueroa K; Ragge NK; Baser ME; Pulst SM
Hum Mol Genet; 1994 Jun; 3(6):885-91. PubMed ID: 7951231
[TBL] [Abstract][Full Text] [Related]
5. Gene discovery using a human vestibular schwannoma cDNA library constructed from a patient with neurofibromatosis type 2 (NF2).
Halum SL; Erbe CB; Friedland DR; Wackym PA
Otolaryngol Head Neck Surg; 2003 Mar; 128(3):364-71. PubMed ID: 12646839
[TBL] [Abstract][Full Text] [Related]
6. Somatic NF2 gene mutations in familial and non-familial vestibular schwannoma.
Irving RM; Moffat DA; Hardy DG; Barton DE; Xuereb JH; Maher ER
Hum Mol Genet; 1994 Feb; 3(2):347-50. PubMed ID: 8004107
[TBL] [Abstract][Full Text] [Related]
7. Clinical manifestations of mutations in the neurofibromatosis type 2 gene in vestibular schwannomas (acoustic neuromas).
Welling DB
Laryngoscope; 1998 Feb; 108(2):178-89. PubMed ID: 9473065
[TBL] [Abstract][Full Text] [Related]
8. Deregulated genes in sporadic vestibular schwannomas.
Cayé-Thomasen P; Borup R; Stangerup SE; Thomsen J; Nielsen FC
Otol Neurotol; 2010 Feb; 31(2):256-66. PubMed ID: 19816230
[TBL] [Abstract][Full Text] [Related]
9. Molecular genetics alterations and tumor behavior of sporadic vestibular schwannoma from the People's Republic of China.
Bian LG; Tirakotai W; Sun QF; Zhao WG; Shen JK; Luo QZ
J Neurooncol; 2005 Jul; 73(3):253-60. PubMed ID: 15980976
[TBL] [Abstract][Full Text] [Related]
10. Microarray analysis of gene expression in vestibular schwannomas reveals SPP1/MET signaling pathway and androgen receptor deregulation.
Torres-Martin M; Lassaletta L; San-Roman-Montero J; De Campos JM; Isla A; Gavilan J; Melendez B; Pinto GR; Burbano RR; Castresana JS; Rey JA
Int J Oncol; 2013 Mar; 42(3):848-62. PubMed ID: 23354516
[TBL] [Abstract][Full Text] [Related]
11. Schwannomas exhibit distinct size-dependent gene-expression patterns.
Mehrian-Shai R; Freedman S; Shams S; Doherty J; Slattery W; Hsu NY; Reichardt JK; Andalibi A; Toren A
Future Oncol; 2015; 11(12):1751-8. PubMed ID: 26075443
[TBL] [Abstract][Full Text] [Related]
12. A non-NF2 case of schwannomas of vestibular and trigeminal nerves with different genetic alterations of NF2 gene: case report.
Kambe A; Kamitani H; Watanabe T; Oka A; Inagaki H; Ishii T; Ueki K
Surg Neurol; 2005 Jan; 63(1):62-4; discussion 64-5. PubMed ID: 15639530
[TBL] [Abstract][Full Text] [Related]
13. Mutation spectrum and differential gene expression in cystic and solid vestibular schwannoma.
Zhang Z; Wang Z; Sun L; Li X; Huang Q; Yang T; Wu H
Genet Med; 2014 Mar; 16(3):264-70. PubMed ID: 24030433
[TBL] [Abstract][Full Text] [Related]
14. Gene-expression profiling elucidates molecular signaling networks that can be therapeutically targeted in vestibular schwannoma.
Agnihotri S; Gugel I; Remke M; Bornemann A; Pantazis G; Mack SC; Shih D; Singh SK; Sabha N; Taylor MD; Tatagiba M; Zadeh G; Krischek B
J Neurosurg; 2014 Dec; 121(6):1434-45. PubMed ID: 25245477
[TBL] [Abstract][Full Text] [Related]
15. Analysis of mutations in the SCH gene in schwannomas.
Bijlsma EK; Merel P; Bosch DA; Westerveld A; Delattre O; Thomas G; Hulsebos TJ
Genes Chromosomes Cancer; 1994 Sep; 11(1):7-14. PubMed ID: 7529050
[TBL] [Abstract][Full Text] [Related]
16. A mosaic pattern of INI1/SMARCB1 protein expression distinguishes Schwannomatosis and NF2-associated peripheral schwannomas from solitary peripheral schwannomas and NF2-associated vestibular schwannomas.
Caltabiano R; Magro G; Polizzi A; Praticò AD; Ortensi A; D'Orazi V; Panunzi A; Milone P; Maiolino L; Nicita F; Capone GL; Sestini R; Paganini I; Muglia M; Cavallaro S; Lanzafame S; Papi L; Ruggieri M
Childs Nerv Syst; 2017 Jun; 33(6):933-940. PubMed ID: 28365909
[TBL] [Abstract][Full Text] [Related]
17. The molecular biology and novel treatments of vestibular schwannomas.
Fong B; Barkhoudarian G; Pezeshkian P; Parsa AT; Gopen Q; Yang I
J Neurosurg; 2011 Nov; 115(5):906-14. PubMed ID: 21800959
[TBL] [Abstract][Full Text] [Related]
18. Molecular biology of vestibular schwannomas.
Chang LS; Welling DB
Methods Mol Biol; 2009; 493():163-77. PubMed ID: 18839347
[TBL] [Abstract][Full Text] [Related]
19. Serial analysis of gene expression in neurofibromatosis type 2-associated vestibular schwannoma.
Halum SL; Popper P; Cioffi JA; Wackym PA
Otol Neurotol; 2004 Jul; 25(4):587-93. PubMed ID: 15241239
[TBL] [Abstract][Full Text] [Related]
20. Genesis and biology of vestibular schwannomas.
Roche PH; Bouvier C; Chinot O; Figarella-Branger D
Prog Neurol Surg; 2008; 21():24-31. PubMed ID: 18810196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]